Tamoxifen is a selective estrogen receptor modulator originally developed as an antifertility drug. It is now commonly used to treat and prevent breast cancer. Tamoxifen undergoes extensive metabolism and is primarily excreted through the bile. It acts as an estrogen receptor antagonist in breast tissue to inhibit cell growth. A special population study found tamoxifen may also be effective for treating brain cancers due to its ability to inhibit protein kinase C and cross the blood-brain barrier.
it reflects cancer especially, focuses on breast cancer, treatment and the current problems related with the drugs; so we can focus on the new targets to treat the disease.
Presentation on Tamoxifen; prevention and treatment for breast cancer. Prepared for Recent Trends in Therapeutics, CLIN 514, at Humber College, November 2011.
it reflects cancer especially, focuses on breast cancer, treatment and the current problems related with the drugs; so we can focus on the new targets to treat the disease.
Presentation on Tamoxifen; prevention and treatment for breast cancer. Prepared for Recent Trends in Therapeutics, CLIN 514, at Humber College, November 2011.
Estrogen
Estrogen receptor and signaling pathway
Introduction of cancer and gene involvement
Causes of breast cancer
Type of breast cancer
Different approaches to treat breast cancer
Estrogen receptor antagonism
estrogen signaling pathway, breast cancer
Estrogen
Estrogen receptor and signaling pathway
Introduction of cancer and gene involvement
Causes of breast cancer
Type of breast cancer
Different approaches to treat breast cancer
Estrogen receptor antagonism
Define cancer and Describe cell cycle.
Able to demonstrate the risk factor, character , diagnosis and treatment of cancer
Able to understand the warning signs of cancer.
List the anti cancer drug classification.
Able to demonstrate the mechanism of cancer drugs.
Describe the toxic effects of anti cancer drugs.
Cancer is the rapid creation of abnormal cells that grow beyond their usual boundaries, and which can then invade adjoining parts of the body and spread to other organs. This process is referred to as metastasis. Metastases are the major cause of death from cancer. (WHO)
Cancer known medically as a malignant neoplasm, is a broad group of diseases involving unregulated cell growth.
In cancer, cellsdivide and grow uncontrollably, forming malignant tumors, and invading nearby parts of the body.
The cancer may also spread to more distant parts of the body through the lymphatic system or bloodstream.
Not all tumors are cancerous; benign tumors do not invade neighboring tissues and do not spread throughout the body.
There are over 200 different known cancers that affect humans.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
4. HISTORY
Originally marketed as a an antifertility drug
and developed in the cornerstone treatment for
breast cancer.
Approved by the FDA for postmenopausal
metastatic breast cancer in 1977
4
5. INTRODUCING TAMOXIFEN
General Use
Breast cancer treatment
and prevention
Proper Name
Tamoxifen Citrate
Chemical Formula
C26H29NO
Chemical Type
non-steroidal Selective Estrogen Receptor Modulator (SERM)
Formulation
Tamoxifen is a fine white powder and delivered orally in pill form
5
6. APPROVED INDICATIONS
Indication Year of Approval
Metastatic Breast Cancer (postmenopausal) 1977
Adjuvant Breast Cancer (postmenopausal, node-positive) 1986
Metastatic Breast Cancer (premenopausal) 1989
Adjuvant Breast Cancer (postoperative and/or chemotherapy
treatment, postmenopausal, node-negative)
1990
Metastatic Breast Cancer (male) 1993
Reduction in Breast Cancer Incidence 1998
Ductal Carcinoma in Situ (DCIS) 2000
6
9. DISTRIBUTION
Tamoxifen is 99% albumin-bound
in serum
Volume of Distribution
50 – 60 L/Kg
This represents an extensive
distribution to the peripheral
tissues
Areas of high concentration
Breast
Lung
Liver
Brain
Bone
Uterus
http://www.sciencephoto.com/media/257869/enlarge
9
10. METABOLISM
Tamoxifen undergoes first-
pass metabolism
Tamoxifen is metabolized
by CYP enzymes
CYP3A
CYP2C9
CYP2D6
Tamoxifen undergoes
enterohepatic circulation
Prolongation of blood
levels and fecal excretion
Liver
CYP-450
GI Tract
Renal Excretion
Tamoxifen
Enterohepatic
circulation
Biliary Excretion
10
11. METABOLISM
Extensive metabolism
following absorption
Demethylation
Hydroxylation
Conjugation
3 major metabolites
are produced
N-desmethyl tamoxifen
4-hydroxy tamoxifen
4-hydroxy-N-desmethyl
tamoxifen (endoxifen)
11
12. EXCRETION
Primary route of elimination
Biliary excretion
65% of administered drug is excreted slowly over a 2
week period
Secondary route of elimination
Renal excretion
Less than 1% excreted via urine
Excreted drug properties
70% are polar conjugates
Indicates high level of metabolism
12
13. PHARMACODYNAMICS
Estrogen receptors (ER)
exist in different tissues
Breast, brain, lung, liver,
bone, uterus
Normal Cellular Function
Estrogen binds to ER
Transcription factor
synthesis
Cell proliferation
13
14. PHARMACODYNAMICS
Selective Estrogen Receptor
Modulator (SERM)
A drug that targets estrogen
receptors in specific tissues
How Tamoxifen Works
Antagonist in breast and
brain
No transcription
Cell growth arrest/apoptosis
Agonist in lung, liver, bone,
and uterus
Normal function
14
15. EFFECT OF DRUG ON BODY SYSTEMS
Tamoxifen also binds and
inhibits
Protein Kinase C
Regulates cell growth and
differentiation
Calmodulin
Mediates process such as
metabolism
P-glycoproteins
Efflux pump
Ca2+ Channels
Signal transduction
Tamoxifen can target mutated cancer cells that lack ER
Tamoxifen
Cell membrane fluidity
Calmodulin
PKC
DNA
ER
transcription
Apoptosis
x
15
16. EFFECT OF DRUG ON BODY SYSTEMS
Most common side
effects (up to 25%
occurrence)
Rarely severe enough to
require discontinuation
of treatment
Hot flashes
Nausea
Vomiting
http://alturl.com/9w7jy
16
17. EFFECT OF DRUG ON BODY SYSTEMS
ADVERSE DRUG REACTIONS BENEFITS OF DRUG
Increased risk of uterine
cancer
Agonist in uterine ER
Increased cell proliferation
Increased risk of blood
clot formation
Increase in clotting factors
Increased risk of cataract
Ophthalmic toxicities
Reduced risk of
breast cancer
ER Antagonist
Strengthens bones
ER Agonist
Lower risk of heart
disease
Increase HDL cholesterol
Reduce LDL cholesterol
17
18. EFFECT OF DRUG ON BODY SYSTEMS
Drug-Drug Interactions
Coumarin-type anticoagulants (Warfarin)
Both 99% bound to albumin
Tamoxifen has a higher affinity for albumin
Co-administration results in a risk of Warfarin over dose
Rifampin (TB Antibiotic)
CYP 34A inducer
Reduces Tamoxifen’s
Bioavailability by 86%
Cmax by 55%
Prozac (Anti-depressant)
CYP 2D6 competitor
Decreases the effect of Tamoxifen
http://alturl.com/apbr2
18
20. ABOUT THE POPULATION
Rational for Special Population
High level of cell proliferation in
brain
Brain cells contain estrogen
receptors
Proliferative signal transduction
in glioma cells has been shown to
occur through a predominantly
Protein Kinase C dependent
pathway
P-glycoprotein functions as a
transporter in the blood-brain
barrier
20
21. PHARMACOKINETICS
Absorption
Oral absorption through the
portal vein into the liver
Excretion
Biliary system
Metabolism
First pass metabolism
CYP 450 enzymes
Distribution
Tissues expressing ER,
including the brain
ADME
21
22. PHARMACODYNAMICS
Tamoxifen is an ER antagonist in the brain
Prevents transcription
Cell growth arrest/apoptosis
Tamoxifen is the only PKC inhibitor small
enough to cross the blood-brain barrier
Inhibits signal transduction
Cell growth arrest/apoptosis
Tamoxifen inhibits P-glycoprotein function
Increased bioavailability of Tamoxifen
22
23. REFERENCES
Avastin (bevacizumab) injection, solution [Genetech, Inc.]. US NLM, NIH, HHS.
Revised 01/2007.
<http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=53695&CFID=6856876
5&CFTOKEN=c7cde62162e43be5-8E980C43-A853-F363-
B83B961222D86D50&jsessionid=ca301da0de303c387869>
Clinical Trials: Tamoxifen. US NLM, NIH, HHS.
<http://clinicaltrials.gov/ct2/results?term=tamoxifen>
Fisher B., Costantino J.P., Wickerham D.L., Redmond C.K., Kavanah M., Cronin
W.M., Vogel V., Robidoux A., Dimitrov N., Atkins J., Daly M., Wieand S., Chiu E.T.,
Ford L., and Wolmark N. 1998. Tamoxifen for prevention of breast cancer: report
of the national surgical adjuvant breast and bowel project p-1 study. Journal of the
National Cancer Institute. 90 (18). 1371-1388
Kleinsmith L.J., Kerrigan D., and Kelly J. 2010. Understanding cancer and related
topics: understanding esrogen receptors, tamoxifen, and raloxifene. National
Cancer Institute.
The Merck Index. 13th Edition. Merck & Co., INC. Whitehouse Station, NJ. 2001.
23
24. REFERENCES
Lien E.A., Solheim E., and Ueland P.M. 1991. Distribution of tamoxifen and its
metabolites in rat and human tissues during steady-state treatment. Cancer
Research. 51. 4837-4844
Mackay H.J. and Twelves C.J. 2003. Protein kinase C: a target for anticancer
drugs.Endocrine-Related Cancer. 10. 389-396
Fisher B., Costantino J.P., Wickerham D.L., Cecchini R.S., Cronin W.M., Robidoux A.,
Bevers T.B., Kavanah M.T., Atkins J.N., Margolese R.G., Runowicz C.D., James J.M.,
Ford L.G., and Wolmark N. 2005. Tamoxifen for the prevention of breast cancer:
current status of the national surgical adjuvant breast and bowel project P-1 study.
Journal of the National Cancer Institute. 97 (22). 1652-1662
Nolvadex (tamoxifen citrate) Tablet [AstraZeneca Pharmaceuticals LP]. US NLM,
NIH, HHS. Revised 01/2007.
<http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3420>
24
25. REFERENCES
Schroth W., Goetz M.P., Hamann U., Fasching P.A., Schmidt M., Winter S., Fritz P.,
Simon W., Suman V.J., Ames M.M., Safgren S.L., Kuffel M.J., Ulmer H.U., Strick R.,
Beckmann M.W., Koelbl H., Weinshilboum R.M., Ingle J.N., Eichelbaum M., Schwab
M., and Brauch H. 2009. Association between CYP2D6 polymorphisms and
outcomes among women with early stage breast cancer treated with tamoxifen.
Journal of the American Medical Association. 302 (13). 1429-1436
Ramachandran C., Khatib Z., Pefkarou A., Fort J., Fonseca H.B., Melnick S.J., and
Escalion E. 2004. Tamoxifen modulation of etoposide sytotoxicity involves inhibition
of protein kinase C activity and insulin-like growth factor II expression in brain tumor
cells. Journal of Neuro-Oncology. 67. 19-28
Couldwell W.T., Hinton D.R., Surnock A.A., DeGiorgio C.M., Weiner L.P., Apuzzo M.L.J.,
Masri L., Law R.E., and Weiss M.H. 1996. Treatment of recurrent malignant gliomas
with chronic oral high-dose tamoxifen. Clinical Cancer Research. 2. 619-622
Mandlekar S. and Kong A.N.T. 2001. Mechanisms of Tamoxifen – Induced
apoptosis. Apoptosis. 6. 469-477.
25